These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 30523244)

  • 41. Role of MiRNAs in Inflammatory Bowel Disease.
    Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
    Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CCAT1 lncRNA Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier via Downregulating miR-185-3p.
    Ma D; Cao Y; Wang Z; He J; Chen H; Xiong H; Ren L; Shen C; Zhang X; Yan Y; Yan T; Guo F; Xuan B; Cui Z; Ye G; Fang JY; Chen H; Hong J
    Inflamm Bowel Dis; 2019 Apr; 25(5):862-874. PubMed ID: 30615124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
    Dharmani P; Chadee K
    Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
    Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
    Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging role of lncRNAs in systemic lupus erythematosus.
    Zhao CN; Mao YM; Liu LN; Li XM; Wang DG; Pan HF
    Biomed Pharmacother; 2018 Oct; 106():584-592. PubMed ID: 29990846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of Disease: Inflammatory Bowel Diseases.
    Ramos GP; Papadakis KA
    Mayo Clin Proc; 2019 Jan; 94(1):155-165. PubMed ID: 30611442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
    Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
    Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genome-wide Pathway Analysis Using Gene Expression Data of Colonic Mucosa in Patients with Inflammatory Bowel Disease.
    Palmieri O; Creanza TM; Bossa F; Palumbo O; Maglietta R; Ancona N; Corritore G; Latiano T; Martino G; Biscaglia G; Scimeca D; De Petris MP; Carella M; Annese V; Andriulli A; Latiano A
    Inflamm Bowel Dis; 2015 Jun; 21(6):1260-8. PubMed ID: 25901971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
    Sato T; Kanai T; Watanabe M; Sakuraba A; Okamoto S; Nakai T; Okazawa A; Inoue N; Totsuka T; Yamazaki M; Kroczek RA; Fukushima T; Ishii H; Hibi T
    Gastroenterology; 2004 Mar; 126(3):829-39. PubMed ID: 14988837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long non-coding RNAs: the epigenetic regulators involved in the pathogenesis of reproductive disorder.
    Shen C; Zhong N
    Am J Reprod Immunol; 2015 Feb; 73(2):95-108. PubMed ID: 25220834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long non-coding RNA expressed in macrophage co-varies with the inflammatory phenotype during macrophage development and polarization.
    Xie Y; Wang M; Tian J; Li X; Yang M; Zhang K; Tan S; Luo L; Luo C; Peng L; Tang A
    J Cell Mol Med; 2019 Oct; 23(10):6530-6542. PubMed ID: 31419045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacterial imbalance and gut pathologies: Association and contribution of E. coli in inflammatory bowel disease.
    Khan S; Imran A; Malik A; Chaudhary AA; Rub A; Jan AT; Syed JB; Rolfo C
    Crit Rev Clin Lab Sci; 2019 Jan; 56(1):1-17. PubMed ID: 30373492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease.
    Sturm A; de Souza HS; Fiocchi C
    Curr Drug Targets; 2008 May; 9(5):381-7. PubMed ID: 18473766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interplay of Immunity and Vitamin D: Interactions and Implications with Current IBD Therapy.
    Abdo J; Rai V; Agrawal DK
    Curr Med Chem; 2017; 24(9):852-867. PubMed ID: 27784213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
    Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Linking immunity, epigenetics, and cancer in inflammatory bowel disease.
    Däbritz J; Menheniott TR
    Inflamm Bowel Dis; 2014 Sep; 20(9):1638-54. PubMed ID: 24896241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IBD candidate genes and intestinal barrier regulation.
    McCole DF
    Inflamm Bowel Dis; 2014 Oct; 20(10):1829-49. PubMed ID: 25215613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.